Список проголосовавших за комментарий " Gapping up/down: XCO +17%, GPRO +10%, JASO +7% and ORCL +6% after earnings/guidance, TSLA +3% after offerings; GES -14% and KNDI -1% after earnings, BIIB -2% after dg at MS<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>XCO</strong> +17.2%, <strong>GALE</strong> +15.3%, <strong>PRTO</strong> +11.8%, <strong>FRSH</strong> +11.7%, <strong>IDRA</strong> +11.5%, <strong>ALRM</strong> +10.3%, <strong>GPRO</strong> +10.2%, <strong>SKLN</strong> +8.2%, <strong>ITEK</strong> +7.2%</li><li><strong>JASO</strong> +6.6%, <strong>CLRB</strong> +6.2%, <strong>ORCL</strong> +6.2%, <strong>SAEX</strong> +5.8%, <strong>MCRB</strong> +5.2%, <strong>SNOA</strong> +4.8%, <strong>RMTI</strong> +3.6%, <strong>CPRX</strong> +3.2%, <strong>SYNC</strong> +3.2%</li><li><strong>WSM</strong> +3.1%, <strong>RTK</strong> +2.7%, <strong>CALL</strong> +1.9%, <strong>YRD</strong> +1.4%, <strong>EVOK</strong> +1.3%, <strong>BTG</strong> +1%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>KGC</strong> +1.2% (Confirms that it has received an unsolicited proposal from Virtu Financial (VIRT) for $18.50-$20.00 per share in cash)</li></ul><p><strong>Select EU financial related names showing strength</strong>:</p><ul><li><strong>BBVA</strong> +4.3%, <strong>SAN</strong> +4.2%, <strong>ING</strong> +2.6%, <strong>DB</strong> +2.3%, <strong>CS</strong> +1.8%</li></ul><p><strong>Select metals/mining stocks trading higher</strong>:</p><ul><li><strong>SWC</strong> +2.7%, <strong>AG</strong> +2.6%, <strong>BBL</strong> +1.8%, <strong>FCX</strong> +1.6%, <strong>BHP</strong> +1.5%, <strong>VALE</strong> +1.5%</li><li><strong>SSRI</strong> +1.4%, <strong>PAAS</strong> +1.4%, <strong>CLF</strong> +1.3%, <strong>GOLD</strong> +1%, <strong>AEM</strong> +1%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>HTBX</strong> +13% (receivse a 3 year, $982k grant from the Florida Department of Health 2016-17 Zika Research Grant Initiative to further develop and test gp96-based Zika vaccine)</li><li><strong>MCRB</strong> +5.2% (Seres Therapeutics and FDA reach agreement on key design elements of a new SER-109 Phase 2 study)</li><li><strong>CTSO</strong> +3.9% (enters into a partnership with Dr. Reddy's Laboratories (RDY) for the South African market)</li><li><strong>TLND</strong> +3.2% (upsizes and prices offering by selling shareholders of 3,289,662 ADSs at $28.50 per share)</li><li><strong>TSLA</strong> +3% (Announces offerings of $250 mln of common stock and $750 mln aggregate principal amount of convertible senior notes due in 2022 in concurrent underwritten registered public offerings)</li><li><strong>DO</strong> +2.3% (Updates on injunction vs. Petrobras (PBR) regarding the Ocean Valor)</li><li><strong>EXK</strong> +2.3% (announces that exploration drilling on the Terronera property)</li><li><strong>AMRN</strong> +2.2% (reports REDUCE-IT Cardiovascular outcomes study remains on schedule to reach onset of target final primary major adverse cardiovascular event near the end of 2017)</li><li><strong>BKS</strong> +1.7% (Board authorizes new stock repurchase program of up to $50 mln of its common shares)</li><li><strong>SPWR</strong> +1.7% (Enters into a Project Supply Agreement with Next Era Energy Resources</li><li><strong>SAP</strong> +1.4% (in sympathy with ORCL earnings)</li><li><strong>EQC</strong> +1.3% (Board adds $150 mln to buyback program)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>LC</strong> +3.2% (upgraded to Buy from Neutral at Guggenheim)</li><li><strong>GBT</strong> +2.6% (Initiated with an Overweight at Cantor)</li><li><strong>ABX</strong> +1.6% (upgraded to Outperform at RBC Capital Mkts)</li><li><strong>GG</strong> +1.6% (upgraded to Sector Perform at RBC Capital Mkts)</li><li><strong>DAL</strong> +1.3% (upgraded to Outperform from In Line at Evercore ISI)</li><li><strong>LITE</strong> +1.2% (upgraded to Neutral from Sell at Goldman)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>GES</strong> -13.6%, <strong>ARTX</strong> -13.4%, <strong>TROV</strong> -8.6%, <strong>INO</strong> -6.8%, <strong>PLX</strong> -6.3%, <strong>CNAT</strong> -5.3%, <strong>CVRS</strong> -2.9%, <strong>INSY</strong> -2.8%</li><li><strong>KPTI</strong> -2.7%, <strong>TTNP</strong> -2.5%, <strong>BCEI</strong> -1.7%, <strong>GV</strong> -1.7%, <strong>KNDI</strong> -1.2%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>IPI</strong> -12% (prices a 43.54 mln share underwritten public offering of common stock for gross proceeds of about $52.3 mln)</li><li><strong>AVID</strong> -6.5% (Postpones conference call to discuss Q4 financial results)</li><li><strong>PEN</strong> -4.1% (Commences an underwritten public offering of 1.3 mln shares of its common stock)</li><li><strong>ELF</strong> -1.3% (Files for $175 mln offering of common stock by selling stockholders)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>BIIB</strong> -2.3% (downgraded to Equal-Weight from Overweight at Morgan Stanley)</li><li><strong>CIEN</strong> -1.6% (downgraded to Neutral from Buy at Goldman; removed from Conviction Buy List)</li><li><strong>SIRI</strong> -1.5% (downgraded to Hold from Buy at Wunderlich)</li><li><strong>MASI</strong> -1.2% (downgraded to Neutral from Overweight at Piper Jaffray)</li><li><strong>UTHR</strong> -1% (initiated with a Underperform at Credit Suisse)</li></ul>"